Top 5 digital health giants you should be watching
Whether or not you personally choose to lead a healthy lifestyle, it’s still significant to note the importance of health and how you should make it a habit to take care of your body on a daily basis.
However, not only is health a popular topic, but technology is, too. It’s quite obvious that we live in a digital world. You have a smartphone, right? So many different options are literally at our fingertips. And when the health and tech industries combine, well, anything seems possible.
Specifically, local governments and entrepreneurs have combined to raise and donate hundreds of millions of dollars to spark innovation in both technology and health care. And the result, according to our sister brand Business Review Canada and HIT Consultant, is the following list that displays the top 5 digital health companies to watch for in Canada.
This product’s technology tracks a child’s eye movements, as well as the user’s long-term progress. Eyeread gives caregivers a quick overview of strengths and weaknesses without having to wait to schedule an appointment with a child psychologist. Expected to be released in 2016, this technology could potentially assist in the diagnosis of learning disorders.
4. Figure 1
Founded in 2012, Figure 1 can be compared to Instagram, but for doctors. This platform was specifically built for doctors by a doctor to share images, opinions and conditions, as well as discuss cases while simultaneously keeping patient records and information private. Figure 1 could eventually reduce the need for referrals, which could then assist patients in saving time and money.
InterAxon assists with the integration into health care diagnoses and treatment. Founded back in 2007, this technology harnesses the power of brainwaves and translates that into digital signals that can be recognized and read by computers. InterAxon is believed to be a solution for helping to decrease stress and anxiety, which are two factors that can greatly change an employee’s productivity and personal achievements.
Myndtec’s technology develops and commercializes innovative medical devices and therapies that are designed to improve function, maximize independence and enhance quality of life. Originally founded in 2008, this company’s FES device can be used in the rehabilitation and treatment of neuromuscular conditions.
1. Seamless MD
Seamless MD can prepare people for upcoming surgeries with pre- and post-op care information, medication reminders, interactive care plans and tools for self-management. Interestingly enough, this tool can also collect data and transmit it to the appropriate caregiver making those providers who use it eligible for certain reimbursement requirements. Furthermore, this platform can help to lower the risk of readmission and post-op complications, which then can increase provider availability for other patients.
What will the health industry come up with next?
[SOURCE: HIT Consultant ]
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”